Takeda, Lilly lose bid to overturn $9 billion award for hiding cancer risk

(Reuters) - Takeda Pharmaceutical Co Ltd and Eli Lilly & Co lost a bid to overturn a combined $9 billion punitive damage award by a U.S. jury for hiding cancer risks associated with their Actos diabetes drug, according to a court ruling.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news